Sign in
Explore the registryTrack Olaparib 300mg's trials

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Olaparib 300mg tabletsOngoingActive not recruitingPhase 3Open NCT01874353 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT01874353 · Trial Tracker · ComplyRx